What are the operative guidelines for repairing a perimembranous ventricular septal defect?

Operative Guidelines for Perimembranous VSD Repair

For perimembranous VSDs, surgical closure is indicated when there is a significant left-to-right shunt (Qp:Qs ≥1.5:1) with evidence of left ventricular volume overload, progressive aortic regurgitation from valve prolapse, or history of endocarditis, using either traditional surgical repair via right atrial approach or transcatheter device closure in selected cases. 1

Indications for Operative Intervention

Absolute Indications (Class I)

• Significant shunt burden: Qp:Qs ≥1.5:1 with left ventricular volume overload 1
• Progressive aortic regurgitation: Even small perimembranous or supracristal defects can cause aortic valve prolapse (occurs in 6% of cases), leading to progressive AR that necessitates closure before valve replacement becomes necessary 1
• History of infective endocarditis: Increased risk in unrepaired VSDs, typically affecting tricuspid and pulmonic valves 1

Relative Indications (Class IIa)

• Moderate shunts with PAH: Qp:Qs ≥1.5 to <2.0 with mild-to-moderate pulmonary hypertension, provided PA systolic pressure is <50% of systemic pressure 1

Contraindications (Class III: Harm)

• Severe pulmonary hypertension: PA systolic pressure >2/3 systemic, pulmonary vascular resistance >2/3 systemic, or net right-to-left shunt (Eisenmenger physiology) 1
• Mortality risk is unacceptably high in this population 1

Surgical Approach Selection

Traditional Surgical Repair

Right atrial approach with direct patch closure remains the gold standard 2:

• Access through right atriotomy
• Critical technical point: Suture patch directly to defect rim using very small bites near the conduction tissue to avoid complete heart block
• Tricuspid valve detachment: Temporarily detach valve near annulus in 36% of cases to improve exposure—this is safe and does not compromise valve function 2
• Expected outcomes: 0% complete heart block, 64% right bundle branch block (benign), 28% tiny residual shunts not requiring reoperation 2

Alternative Surgical Access

• Right subaxillary incision: Provides excellent cosmetic results with similar efficacy to median sternotomy 3, 4
• Aortotomy approach: Reserved for cases requiring concomitant aortic valve surgery (e.g., endocarditis with severe AR) 5

Transcatheter Device Closure

Increasingly viable alternative for selected patients 1:

Ideal candidates:

• Moderate-sized perimembranous VSDs with clear symptoms
• No significant valve regurgitation pre-procedure
• Adequate rim tissue for device anchoring
• Distance from aortic valve ≥2mm (though recent data shows feasibility even closer) 6

Approach options:

• Minimally invasive periventricular device occlusion (MIPDO): Via lower partial median sternotomy under TEE guidance 3, 4
• Transthoracic closure: Via minimal right thoracic or lower sternal incision 4
• Success rate: 96-100% in selected patients 3, 4

Advantages over open surgery:

• Shorter operative time (71 vs 147 minutes)
• Less blood loss (31 vs 115 mL)
• Shorter ventilation duration (97 vs 220 minutes)
• Shorter hospital stay (4.5 vs 6.1 days)
• No cardiopulmonary bypass required 3, 6, 4

Device-specific complications:

• Higher tricuspid regurgitation rate (11.4% vs 4.2% surgical) 3
• Lower right bundle branch block rate compared to surgery 3
• Requires anticoagulation for 3-6 months post-procedure 3
• Atrioventricular block risk: 0-5.9% 6, 4

Critical Technical Considerations

Conduction System Protection

The bundle of His runs along the posteroinferior rim of perimembranous VSDs:

• Type 5 defects (inferior-posterior extension) pose highest risk for heart block 7
• Deploy devices within aneurysmal pouch when present to distance hardware from conduction tissue 7
• Use minimal tissue bites in this region during surgical repair 2

Aortic Valve Management

Type 2 defects (superior-anterior extension) frequently associate with aortic valve prolapse 7:

• Close VSD before AR becomes severe enough to require valve replacement 1
• If device closure chosen, use soft, flexible devices to minimize valve injury 7
• Concomitant aortic valve repair can be performed at time of VSD closure 1

Complex Morphologies

• Type 6 and 7 defects (confluent or complex with outlet involvement) may require multiple devices for complete closure 8, 7
• Modified arteriovenous loop technique enables successful device deployment in defects with aortic valve prolapse 9

Postoperative Surveillance

Routine follow-up echocardiography beyond 1 year post-repair has limited utility in uncomplicated cases 10:

• 97% remain complication-free at 5 years
• New complications after 1 year are rare (3%)
• Continue surveillance only if clinical concerns arise or initial complications present 10

Common Pitfalls to Avoid

1. Operating on Eisenmenger patients: Absolute contraindication with prohibitive mortality risk 1
2. Ignoring progressive AR: Even small defects warrant closure if aortic valve prolapse develops 1
3. Inadequate exposure during surgery: Don't hesitate to detach tricuspid valve temporarily—it's safe and improves visualization 2
4. Device closure in unsuitable anatomy: Patient selection is vital; not all perimembranous VSDs are amenable to transcatheter approach 3
5. Delayed intervention in moderate shunts: 25-year survival drops to 86% for moderate defects vs 96% for small defects when left unrepaired 1